Evidence map›Paper›PMID 26407912›Full record

ArticleHuman immunology2015

Minimum information for reporting next generation sequence genotyping (MIRING): Guidelines for reporting HLA and KIR genotyping via next generation sequencing.

Steven J Mack, Robert P Milius, Benjamin D Gifford, Jürgen Sauter, Jan Hofmann, Kazutoyo Osoegawa, James Robinson, Mathijs Groeneweg, Gregory S Turenchalk, Alex Adai and 15 more

Abstract read
In one paragraph

Article in Human immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Bioinformatics Strategies, Challenges, and Opportunities for Next Generation Sequencing-Based HLA Genotyping.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2019
    Review
  8. Article
  9. Article
  10. Allele-LevelFrontiers in immunology · 2018
    Article
  11. Article
  12. Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2017
    Article
  13. Immunogenomics: using genomics to personalize cancer immunotherapy.Virchows Archiv : an international journal of pathology · 2017
    Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Steven J MackChildren's Hospital Oakland Research Institute, Oakland, CA, USA. Electronic address: SJMACK@CHORI.ORG.
Robert P MiliusNational Marrow Donor Program, Minneapolis, MN, USA.
Benjamin D GiffordOne Lambda, Thermo Fisher Scientific, Brown Deer, WI, USA.
Jürgen SauterDKMS German Bone Marrow Donor Center, Tübingen, Germany.
Jan HofmannDKMS German Bone Marrow Donor Center, Tübingen, Germany.
Kazutoyo OsoegawaDepartment of Pathology, Stanford University, Stanford, CA, USA.
James RobinsonAnthony Nolan Research Institute, Royal Free Hospital, London, UK; University College London Cancer Institute, University College London, London, UK.
Mathijs GroenewegMaastricht University Medical Centre, Maastricht, The Netherlands.
Gregory S TurenchalkBioinformatics, Roche Sequencing, Pleasanton, CA, USA.
Alex AdaiBioinformatics, Roche Sequencing, Pleasanton, CA, USA.
Cherie HolcombRoche Molecular Systems, Pleasanton, CA, USA.
Erik H RozemullerGenDX, Utrecht, The Netherlands.
Maarten T PenningGenDX, Utrecht, The Netherlands.
Michael L HeuerNational Marrow Donor Program, Minneapolis, MN, USA.
Chunlin WangStanford Genome Technology Center, Stanford University, Stanford, CA, USA.
Marc L SalitNational Institute of Standards and Technology, Stanford, CA, USA; Department of Bioengineering, Stanford University, Stanford, CA, USA.
Alexander H SchmidtDKMS German Bone Marrow Donor Center, Tübingen, Germany.
Peter R ParhamDepartment of Structural Biology, Stanford University, Stanford, CA, USA.
Carlheinz MüllerZentrales Knochenmarkspender-Register Deutschland, Ulm, Germany.
Tim HagueOmixon, Budapest, Hungary.
Gottfried FischerMedical University of Vienna, Vienna, Austria.
Marcelo Fernandez-ViňaDepartment of Pathology, Stanford University, Stanford, CA, USA.
Jill A HollenbachDepartment of Neurology, University of California, San Francisco, CA, USA.
Paul J NormanDepartment of Structural Biology, Stanford University, Stanford, CA, USA.
Martin MaiersNational Marrow Donor Program, Minneapolis, MN, USA.

Funding

WHOLE YEAST GENOME TRANSCRIPTIONAL AND FUNCTIONAL GENE MAPS--A FEASIBILITY STUDYP01HG000205 · NHGRI · STANFORD UNIVERSITY · PI DAVIS, RONALD WAYNE, HOWE, ROGER THOMAS · 1990 to 2016
$120.9M
The Role of HLA and KIR in Rheumatoid Arthritis and Crohn's DiseaseU01AI067068 · NIAID · STANFORD UNIVERSITY · PI ERLICH, HENRY A, TRACHTENBERG, ELIZABETH A · 2005 to 2014
$10.9M
Insights Into Immune-Related Diseases Born from Population GenomicsU01AI090905 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Paul John Norman · 2010 to 2026
$10.9M
Integrated Exchange & Storage of Current and Future-Generation Immunogenomic DataR01GM109030 · NIGMS · CHILDREN'S HOSPITAL & RES CTR AT OAKLAND · PI HOLLENBACH, JILL ALLISON, MACK, STEVEN JOHN · 2014 to 2016
$919k
NHGRI NIH HHS P01 HG000205NIAID NIH HHS U01 AI067068NIAID NIH HHS U01AI067068NIAID NIH HHS U01 AI090905NIAID NIH HHS U01AI090905NIGMS NIH HHS R01 GM109030NIGMS NIH HHS R01GM109030
6 · The paper itself

Abstract

The development of next-generation sequencing (NGS) technologies for HLA and KIR genotyping is rapidly advancing knowledge of genetic variation of these highly polymorphic loci. NGS genotyping is poised to replace older methods for clinical use, but standard methods for reporting and exchanging these new, high quality genotype data are needed. The Immunogenomic NGS Consortium, a broad collaboration of histocompatibility and immunogenetics clinicians, researchers, instrument manufacturers and software developers, has developed the Minimum Information for Reporting Immunogenomic NGS Genotyping (MIRING) reporting guidelines. MIRING is a checklist that specifies the content of NGS genotyping results as well as a set of messaging guidelines for reporting the results. A MIRING message includes five categories of structured information - message annotation, reference context, full genotype, consensus sequence and novel polymorphism - and references to three categories of accessory information - NGS platform documentation, read processing documentation and primary data. These eight categories of information ensure the long-term portability and broad application of this NGS data for all current histocompatibility and immunogenetics use cases. In addition, MIRING can be extended to allow the reporting of genotype data generated using pre-NGS technologies. Because genotyping results reported using MIRING are easily updated in accordance with reference and nomenclature databases, MIRING represents a bold departure from previous methods of reporting HLA and KIR genotyping results, which have provided static and less-portable data. More information about MIRING can be found online at miring.immunogenomics.org.

Indexed as

Genotyping TechniquesHistocompatibility TestingResearch ReportGuidelines as TopicHigh-Throughput Nucleotide SequencingHLA AntigensHumansPotassium Channels, Inwardly RectifyingHLA AntigensPotassium Channels, Inwardly RectifyingData standardsGenotypingHLAKIRMIRINGNGS

Identifiers

PMID26407912
PMCPMC4674382

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.